These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6831429)

  • 1. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
    Kufe DW; Major PP; Munroe D; Egan M; Herrick D
    Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
    Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE; Au-Yeung TH
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
    LePage GA; Worth LS; Kimball AP
    Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D; Herrick D; Crumpacker C; Schnipper L
    Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE; Selner M; Phillips JR
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.
    Spriggs D; Robbins G; Mitchell T; Kufe D
    Biochem Pharmacol; 1986 Jan; 35(2):247-52. PubMed ID: 3942598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
    Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
    Matsushita T; Ryu EK; Hong CI; MacCoss M
    Cancer Res; 1981 Jul; 41(7):2707-13. PubMed ID: 7248939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
    Cass CE; Tan TH; Selner M
    Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between the antiproliferative activities of arabinosyladenine and N6-benzyladenosine.
    Tritsch GL; Nechaev A; Mittelman A
    Cancer Biochem Biophys; 1977; 2(2):87-90. PubMed ID: 567524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
    Juranka P; Chan VL
    Cancer Res; 1980 Nov; 40(11):4123-6. PubMed ID: 6162544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cytotoxicity with incorporation of ara-C into DNA.
    Kufe DW; Major PP; Egan EM; Beardsley GP
    J Biol Chem; 1980 Oct; 255(19):8997-900. PubMed ID: 7410404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of biochemical effects and incorporation of 3-deazaguanine into nucleic acids to cytotoxicity in L1210 cells.
    Pieper RO; Barrows LR; Mandel HG
    Cancer Res; 1986 Oct; 46(10):4960-5. PubMed ID: 3756857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.